BPTH · Bio-Path Holdings, Inc. · Exempt Offerings
$0.13
-0.08 (-38.10%)
At close · Feb 19
Return incl. dividend (before tax)
Q3 2024 earnings call transcript
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s available cash and cash equivalents of $0.1 million at March 31, 2026 will not be sufficient to fund liquidity and capital expenditure requirements for the next 12 months from the date of issuance of these consolidated financial statements. Therefore, substantial doubt exists about the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$1.51M
Shares
50.30M
Volume · Feb 19
1.56M
Avg daily vol (3M)
2.45M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-10-22 | New | Biotechnology | $3,995,403 | $3,995,403 | 06b |
| 2024-06-13 | New | Biotechnology | $3,998,370 | $3,998,370 | 06b |
| 2024-04-26 | New | Biotechnology | $1,275,880 | $1,275,880 | 06b |
| 2024-04-05 | New | Biotechnology | $317,929 | $317,929 | 06b |
| 2022-11-18 | New | Biotechnology | $2,280,000 | $2,280,000 | 06b |
Showing 1–5 of 5 filings